Track topics on Twitter Track topics that are important to you
On the heels of its Monday announcement that it would be selling its Save-A-Lot business, Supervalu on Wednesday reported it Q2 2016, reporting a 4.6% decrease in net sales compared to last year.
Original Article: Supervalu Q2 sees 4.6% net sales decreaseNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...